Animal experiments have shown that baicalin can improve renal function and pathological manifestations in lupus model mice by downregulating the activation of NLRP3 inflammasomes and the phosphorylation level of NF-κB (Li et al., 2019). Here, NFKB1 is linked to systemic lupus erythematosus.